It has been found that TCTP expression increases in some types of cancer (colon, lung, prostate, breast, and melanoma) and decreases after tumor reversion, as demonstrated in different cell lines and by knockdown experiments that showed a suppression of the malignant phenotype following inhibition of TCTP expression [12, 13]. Here, TPT1 is linked to melanoma.